Furukawa S - Search Results

1

B cell-activating factor controls the production of adipokines and induces insulin resistance.

Hamada M, Abe M, Miyake T, Kawasaki K, Tada F, Furukawa S, Matsuura B, Hiasa Y, Onji M. Hamada M, et al. Among authors: furukawa s. Obesity (Silver Spring). 2011 Oct;19(10):1915-22. doi: 10.1038/oby.2011.165. Epub 2011 Jun 23. Obesity (Silver Spring). 2011. PMID: 21701571 Free article.

2

Drug-induced hepatitis with autoimmune features during minocycline therapy.

Abe M, Furukawa S, Takayama S, Michitaka K, Minami H, Yamamoto K, Horiike N, Onji M. Abe M, et al. Among authors: furukawa s. Intern Med. 2003 Jan;42(1):48-52. doi: 10.2169/internalmedicine.42.48. Intern Med. 2003. PMID: 12583618 Free article.

3

Esophagogastric varices as a prognostic factor for the determination of clinical stage in patients with primary biliary cirrhosis.

Takeshita E, Kumagi T, Matsui H, Abe M, Furukawa S, Ikeda Y, Matsuura B, Michitaka K, Horiike N, Onji M. Takeshita E, et al. Among authors: furukawa s. J Gastroenterol. 2003;38(11):1060-5. doi: 10.1007/s00535-003-1196-6. J Gastroenterol. 2003. PMID: 14673723

4

[Two cases of asymptomatic primary biliary cirrhosis with ascites].

Hiasa Y, Tokumoto Y, Furukawa S, Takeshita E, Matsui H, Michitaka K, Horiike N, Onji M. Hiasa Y, et al. Among authors: furukawa s. Nihon Shokakibyo Gakkai Zasshi. 2003 Dec;100(12):1400-4. Nihon Shokakibyo Gakkai Zasshi. 2003. PMID: 14748327 Japanese. No abstract available.

5

Significance of study on prevalence of AMA in healthy subjects.

Onji M, Furukawa S. Onji M, et al. Among authors: furukawa s. J Gastroenterol. 2004;39(3):306-8. doi: 10.1007/s00535-004-1312-2. J Gastroenterol. 2004. PMID: 15065014 No abstract available.

6

Vaccine therapy for hepatitis B virus carrier.

Akbar SM, Furukawa S, Horiike N, Onji M. Akbar SM, et al. Among authors: furukawa s. Curr Drug Targets Infect Disord. 2004 Jun;4(2):93-101. doi: 10.2174/1568005043340885. Curr Drug Targets Infect Disord. 2004. PMID: 15180457 Review.

7

Safety and efficacy of hepatitis B surface antigen-pulsed dendritic cells in human volunteers.

Fazle Akbar SM, Furukawa S, Onji M, Murata Y, Niya T, Kanno S, Murakami H, Horiike N. Fazle Akbar SM, et al. Among authors: furukawa s. Hepatol Res. 2004 Jul;29(3):136-141. doi: 10.1016/j.hepres.2004.03.003. Hepatol Res. 2004. PMID: 15203076

8

Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.

Akbar SM, Furukawa S, Hasebe A, Horiike N, Michitaka K, Onji M. Akbar SM, et al. Among authors: furukawa s. Int J Mol Med. 2004 Aug;14(2):295-9. Int J Mol Med. 2004. PMID: 15254781

9

Hepatopulmonary syndrome in a patient with primary biliary cirrhosis.

Hamada M, Tokumoto Y, Furukawa S, Minami H, Hiasa Y, Michitaka K, Horiike N, Onji M. Hamada M, et al. Among authors: furukawa s. Intern Med. 2004 Jun;43(6):458-60. doi: 10.2169/internalmedicine.43.458. Intern Med. 2004. PMID: 15283179 Free article.

10

Induction and maintenance of anti-HBs in immunosuppressed murine hepatitis B virus carriers by a novel vaccination approach: implications for use in hepatitis B virus-infected subjects with liver transplantation.

Furukawa S, Akbar SM, Hasebe A, Horiike N, Onji M. Furukawa S, et al. J Gastroenterol. 2004 Sep;39(9):851-8. doi: 10.1007/s00535-004-1401-2. J Gastroenterol. 2004. PMID: 15565404

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,900 results

Search Page

Filters